BlackThorn: Consortium creates a 'behavioral biomarker' through AI models
The AI technology company BlackThorn joins a consortium to develop predictive models for neurobehavioral disorder clinical trial inclusion criteria.
Read full article »
BlackThorn is a biopharmaceutical company that discovers and develops novel targeted therapeutics for the treatment of neurobehavioral disorders.
Read more